The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis

In recurrent or metastatic gastric cancer, second-line chemotherapy is generally recommended in current guidelines. Although third-line therapy is often performed in daily practice in some countries, there are only a few reports about its benefits. A retrospective review was conducted on 682 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yong Won, Ahn, Mi Sun, Jeong, Geum Sook, Lee, Hyun Woo, Jeong, Seong Hyun, Kang, Seok Yun, Park, Joon Seong, Choi, Jin-Hyuk, Sheen, Seung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181587/
https://www.ncbi.nlm.nih.gov/pubmed/30278571
http://dx.doi.org/10.1097/MD.0000000000012588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181587/
https://www.ncbi.nlm.nih.gov/pubmed/30278571
http://dx.doi.org/10.1097/MD.0000000000012588

Ejemplares similares